BioSpace News Archive

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter 2019 and reviewed recent business highlights.

An Affiliate of the National Association of Community Health Centers - via the Value in Benefits Program to Provide Access to Affordable Employee Healthcare for Community Health Centers in California

Vizient, Inc. has released its July 2019 Drug Price Forecast projecting health systems, including inpatient and non-acute environments, can expect a 4.57 percent increase for pharmaceutical purchases made from Jan. 1, 2020 to Dec. 31, 2020.

Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2019.

Leap Therapeutics, Inc. announced that its anti-Dickkopf-1 antibody, DKN-01, in combination with Merck’s anti-PD-1 antibody, Keytruda®, demonstrated higher survival and objective response outcomes in patients with advanced gastroesophageal junction and gastric cancer whose tumors expressed high levels of DKK1.

Allergan plc reported its second quarter 2019 financial results including GAAP net revenues of $4.09 billion, a 0.8 percent decrease from the prior year quarter.

The conference will be held at the InterContinental Hotel in Boston, MA.

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that, for the fourth consecutive year, its Ortho Care™ service and support program was ranked No. 1 in the diagnostics industry.

Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today reported financial results for the three- and six-months ended June 30, 2019.

Researchers from TARA Biosystems, Inc. and GlaxoSmithKline (GSK) today published data demonstrating that TARA’s engineered heart-on-a-chip system replicated drug responses found in adult humans.